Funding Rounds
Flindr Therapeutics

Flindr Therapeutics Series A (2024, $21M)

Flindr Therapeutics

Precision oncology treatments developer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $21.38M

Investors